12 Health Care Stocks Moving In Wednesday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's after-market session, several healthcare stocks showed notable movements. Acrivon Therapeutics, Amarin Corp, and Universe Pharmaceuticals were among the top gainers, with increases of 12.3%, 8.12%, and 7.47% respectively. On the losing side, Akili, BiomX, and OneMedNet experienced declines of 11.3%, 5.24%, and 4.84% respectively. Biomarin Pharmaceutical also fell by 3.49% following its Q1 earnings release.
April 24, 2024 | 8:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Acrivon Therapeutics stock rose 12.3% to $10.67, with a market value of $329.4 million.
The significant after-market gain for ACRV suggests positive investor sentiment, potentially due to company-specific news or broader sector movements.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Amarin Corp stock increased by 8.12% to $0.95, with a market cap of $381.2 million.
Amarin Corp's rise in the after-market session could indicate investor optimism, possibly driven by recent company developments or favorable market conditions.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 90
NEGATIVE IMPACT
Akili shares decreased by 11.3% to $0.22, with a market cap of $17.2 million.
The decline in Akili's stock price could reflect negative market reaction to recent company news or broader market trends affecting the healthcare sector.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
Biomarin Pharmaceutical shares fell 3.49% to $88.02 following its Q1 earnings release, with a market value of $16.7 billion.
Biomarin's stock price drop post-Q1 earnings suggests the market's reaction may have been negative, possibly due to earnings not meeting expectations.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 95